Ironwood Pharmaceuticals (IRWD) Raw Materials (2016 - 2019)

Ironwood Pharmaceuticals has disclosed Raw Materials across 4 years of filings, most recently posting $65000.0 for Q4 2019.

• Raw Materials for Q4 2019 came in at $65000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $65000.0 (changed N/A YoY), and the FY2019 annual result was $65000.0, changed N/A from the prior year.
• Raw Materials came in at $65000.0 for Q4 2019 at Ironwood Pharmaceuticals, down from $1.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.5 million in Q1 2017 to a low of $65000.0 in Q4 2019.
• The 4-year median for Raw Materials is $801500.0 (2016), against an average of $800750.0.
• Across the five-year window, Raw Materials tumbled 79.64% in 2018 and soared 378.9% in 2019, its largest moves.
• Ironwood Pharmaceuticals' Raw Materials stood at $1.0 million in 2016, then surged by 49.8% to $1.5 million in 2017, then sank by 79.64% to $308000.0 in 2018, then plunged by 78.9% to $65000.0 in 2019.
• The last three Raw Materials figures came in at $65000.0 (Q4 2019), $1.1 million (Q3 2019), and $1.5 million (Q2 2019), per Business Quant data.